Unique RNA technology
paired with big data analytics.
We combine CAP-CLIA certified RNA sequencing and unequaled machine learning algorithms to find relevant biomarkers that provide insight into the nature of disease. Analogous to associating a fingerprint to an individual, numerous diseases can be identified by a unique molecular profile.
We are the leaders
in Ribonucleic acid.
As industry leaders in RNA-based discovery services, our team has spent the last five years applying unique analysis to thousands of the most challenging RNA samples. Today we have contracts with 9 of the world’s largest Pharma to develop RNA based solutions to drive their pre-clinical studies
We have moved RNA out of discovery and into the clinic.
Our standardized, validated, and CAP-CLIA certified RNA diagnostic tests are being used to validate DNA and protein assays, drive efficacy of treatment through patient stratification, and enable development of prognostic and diagnostic RNA markers.